There is a large discrepancy between the changes in drug coexisting difference in cellular sensitivity has repeatedly been accumulation and the changes in drug cytotoxicity that demonstrated. 4,5 In a number of studies, sensitive cells accompany development of anthracycline in multidrug-resistaccumulated two to 10 times more drug than multidrug-resist- and subsequent subcellular targeting of endosomes; (5) altered Keywords: anthracycline; microspectrofluorometry; cellular distribution; cell death; multidrug resistance; reversal rates and extent of exocytosis; (6) modified ionic environment, such as pH, calcium concentration of extra-, intra-, or subcellular compartments; and (7) alterations of the activity and expression of proteins necessary for drug detoxification and Introduction DNA replication and repair systems. 20 Concerning the plasma membrane composition and its implication in drug-resistance Anticancer drugs have been shown to target diverse intracelluphenomena, lipids components were shown to be important lar elements in conferring lethal effect in tumor cells.
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1-3 A disin determining the extent of daunomycin binding to the memparity between the defect in drug accumulation and the branes and in establishing the observed resistance-related differences in drug binding.
DNA. In addition, some authors have reported that anthracysame optics. 35 The required discrimination between optical sections is controlled by varying the aperture of a square pinclines could also interact with both the internal and the external membrane structure of the cell, as follows: (1) binding to hole from 50 to 100 m. For intracellular measurements of anthracycline emission, the pinhole size is fixed to an aperture the phospholipid cardiolipin of the mitochondrial membrane; 1, 22 (2) peroxidation of membrane unsaturated lipof 200 m. Using this configuration, and by comparison with fluorescent beads of known diameters, confocal sections are ids 23 and interaction with the external cell membrane of anthracyclines immobilized on insoluble nanoparticles estimated to be about 2 m. A Notch filter (Oriel, Paris, France) is used to decrease the scattered light intensity from inducing cytotoxicity. 24 Although different molecular targets for anthracyclines could be involved, mechanisms by which the excitation line by 10 12 -fold. The microscope is coupled with a single-grating (300 grooves/mm) spectrograph through these compounds exert their cytotoxic and differentiating effects remain unclear.
the confocal entrance chamber. The fluorescence emission of treated cell is analyzed with an air-Peltier-cooled CCD detecIt has been reported that the lethal activity of some intercalating agents, including anthracyclines, appears to be more tor (Wright, Enfield, UK) supplied by an 1125 × 298 pixel sensor element and optically coupled to an image closely correlated with DNA-double strand breaks. 25, 26 These results support the hypothesis of the nucleus as a target for intensifier. 36 cytotoxic action. According to this, nucleocytoplasmic distribution and compartmentalization of anthracyclines have already been investigated, using confocal fluorescence
Determination of the nuclear anthracycline concentration
microscopy, on both sensitive and resistant tumor cells.
27-29
This technique does not take into account the modifications which can affect the fluorescence profile of the drug, such as For experimental details, the example of doxorubicin (DOX) will be presented. Several observations have suggested that quenching and spectral shift of a few nanometers due to different molecular environments or specific interaction with the the cell nucleus is the target of doxorubicin: (1) 70% of intracellular DOX is located in the nucleus, where its concentarget. One significant example is the study reported by Egorin and co-workers. 30 In this paper, they have shown a preferentration is 100-fold higher than its extracellular medium; 37 and (2) DNA strand-breaking is evidenced in cells exposed to tial localization of aclacinomycin A in the cytoplasm of tumor cells, and they concluded that the main target of this anthraanthracyclines. 38 Anthracyclines have a high affinity for double helix nucleic acids, by intercalating between base cycline is the cytoplasmic compartment. Later, using confocal laser microspectrofluorometry, we showed that the fluorpairs. 39 This affinity has also been reported on tumor cells using resonance Raman and surface-enhanced Raman scatescence of aclacinomycin A located in the nucleus is quenched 200 times upon binding to nuclear DNA. 31 Thus, tering microspectroscopies. 40, 41 Knowing the potential target of DOX (Figure 1 ) in the cell by measuring absolute concentrations of nuclear anthracyclines, we were able to study the real drug transport. In the nucleus, ie DNA, two spectral models can be used in order present review, we report data from our laboratory which are in agreement with an action mechanism of anthracyclines targeted to the nucleus. First, we have shown that identical nuclear doxorubicin induces the same degree of cytotoxicity, independent of cellular MDR phenotype and the anthracycline structure. Then, we were able to acquire information on the mechanisms of resistance related to drug transport. Some examples of the modulation of this accumulation will be given. For clinical applications, our studies have dealt with in vitro measurements of drug efflux from nuclei of acute leukemia cells and its correlation with the P-glycoprotein expression. An exception, from preliminary data, shows that modulation of multidrug-resistance by quinine is not accompanied by a significant increase of anthracycline nuclear accumulation. This result will be discussed, compared to a similar study, 4 in terms of the existence of probably other cell targets of anthracyclines, 1-3 and other ways which could protect tumor cells from their cytotoxic effects.
6,32-34

Methodology: Confocal laser microspectrofluorometry
The microspectrofluorometer
Emission spectra from confocal sections within a living cell are recorded using confocal laser microspectrofluorometer (DILOR, Lille, France). An optical microscope (Olympus BH2, Paris, France) equipped with a water immersion objective lens (100×, NA 0.95), allows (1) observation of the sample; (2) focusing of a 4 W laser beam emitting at 457.9 nm (2065A fluorescence emission in the 500-700 nm range through the to model the environment of DOX in the cell nucleus: (1) a responds to a system of 100 equations, which are resolved by minimization of (2) with a least squares algorithm, and leads model of the free drug; and (2) a model of the drug bound to DNA. For microspectrofluorometric analysis, K562 human to DOX concentrations (C r , C b ) in the living cell nucleus. leukemia cells are incubated in the medium containing DOX.
(2) Then, cells are washed free of drug in cooled PBS at 4°C and seeded in a Petri dish containing PBS. All reported data have A fluorescence emission spectrum, as determined from a been performed on a sample of 20-30 different cell nuclei selected microvolume in the nucleus of a K562 cell after within the first 15 min after transferring cells in PBS. Under exposure to DOX, is shown in Figure 2b . The resolution into these experimental conditions, the nuclear concentration of three spectral contributions leading to the computed DOX DOX remained essentially unaffected (approximately 5%).
concentration, is also shown in Figure 2b . Twenty spectra from the same intracellular location were Nuclear DOX concentrations are determined with an error accumulated in order to increase the signal to noise ratio.
of less than 10%. This quantitative analysis technique was The fluorescence signal F() at a given wavelength, arising validated by comparison with the measurement of 14 C-DOX from the nucleus of a cell treated with DOX, can be expressed uptake. 42 Measurements carried out in 20 to 30 cells have as a sum of spectral contributions of free DOX, DNA-bound allowed determination of the kinetics of nuclear uptake of DOX and an intrinsic nuclear signal, ie:
DOX, leading to the following conclusions: (1) in the cell nucleus, more than 99% of DOX is bound to DNA; and (2)
DOX is highly concentrated in the cell nucleus, in K562 cells incubated for 4 h, the concentration of nuclear DOX is 100 where F r and F b are the fluorescence spectra of free and bound drug referred to as a unitary concentration. Taking into times higher than the extracellular DOX concentration. Multidrug resistant K562-DOX cells (resistance factor = 25) display account the concentrations of free and bound drug respectively, ␣ is the contribution of the nuclear component responlower nuclear DOX accumulation than sensitive K562 cells 42 ( Figure 3 ). sible for the intrinsic nuclear spectrum F n . References spectra, corrected for buffer contribution, for free DOX (0.12 M) (F f ) in PBS solution and DOX (2 M) bound to DNA (concentration in phosphate: 1 mM) in PBS (F b ) are presented
Results and discussion in Figure 2a , after normalization of the integrated surfaces. The fluorescence yield of DOX in the free form is higher than
Quantitative determination of factors contributing to anthracycline-induced cell death
that of the bound form by a factor of 48 ± 2.
Using the resolution of the CCD detector, equation (1) 
corCorrelation between doxorubicin nuclear accumulation and its growth inhibitory and differentiation effects in K562 human leukemic cells:
It has already been reported that different incubation temperatures and in spite of the same intracellular anthracycline amount, the observed decrease in drug cytotoxicity leads to the suggestion that temperature-dependent cytotoxic effects may be mediated by drug interaction with the cell membrane.
1,43 DOX induces erythroid differentiationassociated properties in human K562 leukemic cells. In con- trast to what was reported in Refs 1 and 43, and in order to 4′-deoxy-4′-iododoxorubicin (IDX, Figure 1 ), a DOX analogue with greater lipophilicity. 46 DOX-resistant K562 cells overexstudy the relationship between the nuclear accumulation of DOX and the observed biological effects, the influence of press the P-glycoprotein responsible for active drug efflux. 31 For our purposes the comparison with DOX was very interestincubation temperatures on these processes was studied. Differentiation was assessed by the count of recruited hemoglobiing, because this analogue is taken up faster and to a higher extent by the cells, and shows reduced cross-resistance with nized cells after exposure to DOX at 37°C and 4°C. Microspectrofluorometry was used to measure nuclear DOX DOX. A correlation has been established between drug concentration measured in the nucleus and cell growth inhibition concentrations. When incubation temperatures led to the same nuclear DOX concentrations, with eight times more for both drugs. In fact, the same drug concentration was found in the nuclei of DOX-sensitive and DOX-resistant K562 cells DOX in the medium at 4°C than at 37°C, cell growth and differentiation percentages turned out to be similar (Figure 4 ). when exposed to several corresponding growth inhibition concentrations. 45 Growth inhibitory concentrations of K562 Moreover, in our conditions the DOX concentration in the cell nucleus had to overstep 10 M to induce a significant difand DOX-resistant K562 (K562-DOX) cells, when measured with respect to drug content in the medium, differed by a facferentiation. We concluded that, in agreement with the hypothesis implicating the nucleus as a cellular target of DOX, tor of 25 in the case of DOX and by a factor of three in the case of IDX (Figures 5a and b ). By contrast, nuclear drug conerythroid differentiation and growth inhibitory effects induced by DOX are dependent on the amount of drug initially incorcentrations measured at corresponding growth inhibitory concentrations are found to be nearly constant, ie independent of porated into the cell nucleus. In this study, drug accumulation into the nuclei of DOX-sensitive and DOX-resistant K562 human leukemia cell lines has been compared for DOX for
Quantitative determination of factors contributing to anthracycline MDR resistance and its reversal Role of anthracycline association in reversal of doxorubicin resistance in K562 cells:
P-glycoprotein-mediated multidrug-resistance (MDR) is now recognized as an important cause of failure of cancer chemotherapy 47 (for a review, see Introduction section). A previous report showed that high aclacinomycin A or ACM (Figure 1 ) levels (10 g/ml), in combination with DOX or daunomycin, increased the intracellular amount of the latter compounds with concomitant increased cytotoxicity against resistant cells. 48 We have extended these inhibition growth studies with nontoxic doses of ACM against DOX-resistant K562 cells in order to determine which kind of exposure with ACM and DOX, simultaneously or sequentially, produced the most cytotoxicity. 31 Cells were incubated for 4 h in the presence of DOX with and without nontoxic ACM concentrations (growth inhibition Ͻ5%): 10 nM for K562, 50 nM for K562-DOX. For the K562 cell line (Figure 6a) , simultaneous incubation with DOX and nontoxic ACM dose (10 nM) did not produce any enhancement of DOX cytotoxicity. On the contrary, for the resistant cell line, incubation with DOX and nontoxic ACM dose (50 nM) promoted a partial restoration of the DOX activity (Figure 6b) . Then, K562-DOX cells were exposed to ACM and DOX, according to two different associations in order to compare their cytotoxic activity:
(1) simultaneous exposures with ACM and DOX; and (2) ACM pretreatments, followed by DOX alone (Figure 6c ). Compared to the ACM pretreatments, simultaneous exposure to both anthracyclines produced higher cell growth inhibitions. This observation became more evident for ACM and DOX doses superior to 1 M. To explain the reversal of resistance by ACM, we have measured the DOX uptake directly into nuclei of living cells, using microspectrofluorometry. Kinetics of DOX uptake and DOX retention from sensitive and resistant cell nuclei have been studied with and without simultaneous ACM incubation. For this, the nuclear spectral analysis must take into account two additional contributions derived from the following compounds: (1) ACM, and (2) 7-deoxyaklavinone, termed C 1 . The fluorescence yields of free ACM is 200 times higher than that bound to DNA. C 1 results from an enzymatic cleavage of the trisaccharide and has been isolated and identified by HPLC 49 and microspectrofluorometric studies. Thus, equation (1) in the Methodology section becomes:
Where F a and F c are fluorescence spectra of ACM and C 1 respectively. ␤ and ␥ are their surface contributions in the nuclear spectrum F() of a K562 after exposure to DOX and ACM. Minimization of (4) with a least squares algorithm, leads to DOX concentrations in the living cell nucleus.
To determine whether co-incubation with ACM produces an enhancement of DOX nuclear concentration, we have measured nuclear concentrations of DOX by microspectrofluorometry, as a function of extracellular doses of ACM. This relationship is shown in Figure 7b . For K562-DOX cells, DOX nuclear concentrations increased proportionally with ACM extracellular doses. The time-course of DOX nuclear uptake and in vivo. 54 Pierre et al observed through in vitro experiments that S9788 was more active when combined with a vinca-alkaloid derivative, vincristine or vinblastine, than with DOX. However, a study investigating K562-DOX cells, showed that S9788 (5 M) is able to restore accumulation of daunorubicin (DNR) (measured by flow cytometry) to a level similar to that measured in sensitive K562 cells. 52 For this reason, we proposed, using microspectrofluorometry, to study intracellular THP-doxorubicin or THP-DOX (Figure 1 ) distribution, particularly its nuclear accumulation with or without S9788, cyclosporin A and verapamil. The kinetics of nuclear accumulation of THP-DOX (1 M in the medium), as a function of time, is rapid in K562 and K562-DOX cells compared to DOX. 55 In addition, we studied the efflux of THP-DOX from nuclei of K562-DOX cells after 3 h of incubation without THP-DOX and calculated the T . value of efflux. This was compared to that obtained when S9788, CsA and VPL were added to K562-DOX cells in THP-DOXfree medium. The first finding was that S9788 was more active than cyclosporin A and verapamil on the restoration of nuclear THP-DOX in K562-DOX. We tried to correlate those data with results obtained in the growth inhibition study. The IC 50 (concentration which induces 50% growth inhibition) of THP-DOX, corresponding to a 1h THP-DOX treatment and 3 days culture of K562 and K562-DOX cells was measured. These data were compared to quantitative measurements, in order to understand if only a higher affinity of S9788 for membrane P-glycoprotein of K562-DOX cells can explain its higher activity, or an additional mechanism of action could be implied in restoration of THP-DOX activity. Results are summarised in Table 1 . Our data support the hypothesis that S9788 causes a modulation of resistance by binding to P-glycoprotein and thereby inhibiting drug efflux. However, the increase of T . of THP-DOX efflux was only about 7.5 times (90 min vs 12 min), and nuclear uptake of THP-DOX was increased approximately by the same factor (290 M vs 40 M) and represents only 70% of that found in K562, compared to the drastic 20-fold decrease in the resistance factor (see Table 1 ). The biochemical bases for reversal of MDR by chemosensitizers remain unclear. Although these agents are believed to act by increasing cellular drug accumulation ter them in others, such as in intracellular vesicles, may lead and the P-glycoprotein 7 or from an altered expression of this [52] [53] [54] This molecule has been shown to reverse acquired MDR at lower concentrations than verapamil in vitro to the increased retention of the drug. 60 In this study we have shown that S9788-induced THP-DOX reversion was nearly complete in the K562-DOX model as it has been demonstrated for DNR and this property is not restricted only to vinca-alkaloid derivatives.
Contribution to the evaluation in vitro of multidrug-resistance phenotype in leukemia cells from patients:
Resistance to chemotherapeutic agents is an important factor of treatment failure in acute leukemias. Many methods for determining mdr1 gene expression have been used. Mdr1 RNA levels can be determined by Northern or slot blot hybridization or polymerase chain reaction analysis. P-glycoprotein expression is detected by Western blot analysis or immunohistochemical staining using several MDR-specific monoclonal antibodies. 61 However, at the present time, there exists no universally standardized method. 62 In the French experience, from a multicentric study, we found that MDR phenotype detection is not simple on clinical samples (Marie JP, this issue). Moreover, the methods cited above do not take into account the functional character of P-glycoprotein, particularly the intracellular distribution of anticancer drugs. Finally, other mechanisms of resistance to chemotherapy, independent of P-glycoprotein, have been described to alter the intracellular pharmacokinetics of anti-cancer drugs. 63 Following these arguments, the availability of other methods to study the intracellular metabolism of anticancer agents is essential. Only these methods can allow the investigation of the functional aspect of P-glycoprotein or other resistance mechanisms that also operate by modifying the intracellular and distribution of drugs.
64-71
Nuclear DOX quantitation in living leukocytes from patients, using microspectrofluorometry, has already been reported. 72 Thus, possibilities for this technique have been revealed in non-pathological human cells. Because it only (Figure 8c ). Among 18 patients presenting with AML at diagnosis, 14 have been treated with After 1 h incubation at 37°C, cells were washed and the first half of each sample was analyzed by microspectrofluorometry intensive chemotherapy including anthracyclines. The only one who had resistant disease had the lowest RR value. In to give the nuclear accumulation of THP-DOX (C 1h ). The second half of each sample was resuspended in fresh medium conclusion, the results obtained show that microspectrofluorometry allows studies on fresh leukemic cells in order to free of drug and incubated for 3 h at 37°C. Then, cells were washed and analyzed in order to determine residual nuclear quantify chemoresistance phenomena related to drug transport. 55 THP-DOX (C 3h ). These two measurements permit calculation of the retention rate (RR = 100 × [C 3h /C 1h ]) of nuclear THP-DOX after 3 h of efflux. Besides, all samples were analyzed for (1) expression of P-glycoprotein using the monoclonal antiConclusion body C219 and immunohistochemical method; and (2) CD34 expression using FITC-conjugated monoclonal antibody
Is reversal via 'drug transport' the only way to overcome MDR phenotype?
QBEND10 and flow cytometry. RR was determined for K562 and K562-DOX cells in the same conditions as leukemic cells. RRs were respectively 40 and 5%. Figure 8a shows that initial
In this review, we tried to contribute to the quantitation of MDR phenotype by studying (1) nuclear accumulation; (2) nuclear accumulation of THP-DOX was poorly correlated (n = 33, r = −0.337; P Ͻ 0.05). There were also large variations retention; and (3) distribution of anthracyclines in MDR leukemic cells. The main important finding is that nuclear distrifrom one patient to another and RR varied in the range of 8 to 98%. Moreover RR did not correlate with either P-glycobution of anthracyclines is necessary to induce growth inhibi-tory and differentiation effects. For clinical applications, our cosyl-ceramides in MDR cells. All these differences could be factors which probably inhibit anthracycline-induced prostudies have already dealt with nuclear concentration measurements of doxorubicin in leukocytes in treated grammed cell death. 33 Quinine and other modulators could perturb the lipidic environment of MDR cells leading to an patients, and in vitro measurements of drug efflux from nuclei of acute leukemia cells and its correlation with the P-glycoincrease of anthracycline activity via 'lipid metabolism or apoptosis' mechanisms. 6, 21, 34 In this case, an interesting perprotein expression. However, in these studies, there was no correlation between anthracycline nuclear accumulation in spective in the clinic should be the development of new strategies and compounds in order to overcome MDR not only via vitro and P-glycoprotein expression. According to several studies on the potential of a number of small and lipophilic P-glycoprotein but other pumps implicated in drug transport. cations to reverse in vitro the resistance to anthracyclines and other natural products through their interaction with P-glycoprotein, we could give evidence that this accumulation is Acknowledgements increased when MDR modulators, such as verapamil and S9788, and cyclosporin A or anthracyclines, are used. Some
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